Olivia
Online
Kelly@ECP
@ECP_editor
Joined November 2022
11 Following
46 Followers
95 Posts
Call for Papers from Experimental and Clinical Psychopharmacology. Special Issue on Real-World Challenges in Substance Use Behaviors: comorbidities, polysubstance use, and translational approaches. Clinical, preclinical, and population studies welcome. Deadline: July 1, 2026.
Call for Papers from Experimental and Clinical Psychopharmacology. Special Issue on Real-World Challenges in Substance Use Behaviors: comorbidities, polysubstance use, and translational approaches. Clinical, preclinical, and population studies welcome. Deadline: July 1, 2026.
Call for Papers from Experimental and Clinical Psychopharmacology. Special Issue on Real-World Challenges in Substance Use Behaviors: comorbidities, polysubstance use, and translational approaches. Clinical, preclinical, and population studies welcome. Deadline: July 1, 2026.
Call for Papers from Experimental and Clinical Psychopharmacology. Special Issue on Real-World Challenges in Substance Use Behaviors: comorbidities, polysubstance use, and translational approaches. Clinical, preclinical, and population studies welcome. Deadline: July 1, 2026.
Call for Papers from Experimental and Clinical Psychopharmacology. Special Issue on Real-World Challenges in Substance Use Behaviors: comorbidities, polysubstance use, and translational approaches. Clinical, preclinical, and population studies welcome. Deadline: July 1, 2026.
Call for Papers from Experimental and Clinical Psychopharmacology. Special Issue on Real-World Challenges in Substance Use Behaviors: comorbidities, polysubstance use, and translational approaches. Clinical, preclinical, and population studies welcome. Deadline: July 1, 2026.
Call for Papers from Experimental and Clinical Psychopharmacology. Special Issue on Real-World Challenges in Substance Use Behaviors: comorbidities, polysubstance use, and translational approaches. Clinical, preclinical, and population studies welcome. Deadline: July 1, 2026.
Call for Papers from Experimental and Clinical Psychopharmacology. Special Issue on Real-World Challenges in Substance Use Behaviors: comorbidities, polysubstance use, and translational approaches. Clinical, preclinical, and population studies welcome. Deadline: July 1, 2026.
Call for Papers from Experimental and Clinical Psychopharmacology. Special Issue on Real-World Challenges in Substance Use Behaviors: comorbidities, polysubstance use, and translational approaches. Clinical, preclinical, and population studies welcome. Deadline: July 1, 2026.
ECP introduces Consulting Editor Dr. Elise Weerts Ph.D., from the Johns Hopkins University School of Medicine.
Follow us for late-breaking publications and submit your manuscripts at https://t.co/rxHoiE2OjS
ECP introduces Consulting Editor Dr. Yukiko Washio Ph.D., BCBA-D from RTI International.
Follow us for late-breaking publications and submit your manuscripts at https://t.co/rxHoiE2OjS
Rzeszutek et al., outline a new demand model that prevents the need to remove the parameter k. Removal of this span parameter allows for uniform interpretation of results across commodities while still normalizing data across initial consumption value https://t.co/G8tyNIsEPT
ECP introduces Consulting Editor Dr. Orrin Ware Ph.D. MPH, MSW, from the University of North Carolina
Follow us for late-breaking publications and submit your manuscripts at https://t.co/rxHoiE2OjS
ECP introduces Consulting Editor Dr. Antover Tuliao Ph.D., from Texas Tech University
Follow us for late-breaking publications and submit your manuscripts at https://t.co/rxHoiE2OjS
Gilroy et al., provide a comprehensive demonstration of how machine learning and reinforcement learning can directly assist in research related to substance use and various other domains employing behavioral economic methodologies. https://t.co/qjDtgJqGxh
ECP introduces Consulting Editor Dr. D. Andrew Tompkins, M.D. from the University of California, San Francisco
Follow us for late-breaking publications and submit your manuscripts at https://t.co/rxHoiE2OjS
ECP introduces Consulting Editor Dr. Michael Taffe Ph.D., from the University of California, San Diego
Follow us for late-breaking publications and submit your manuscripts at https://t.co/rxHoiE2OjS
Verner et al., found patients with prescription opioid use disorder had greater
spontaneous drug cravings and cravings elicited by prescription opioid stimuli vs. healthy controls and that cravings were associated with higher depression and anxiety ratings https://t.co/CKKCUv9VIT
ECP introduces Consulting Editor Dr. WIlliam Stoops Ph.D., from the University of Kentucky
Follow us for late-breaking publications and submit your manuscripts at https://t.co/rxHoiE2OjS
ECP introduces Consulting Editor Dr. Justin Strickland Ph.D., from the Johns Hopkins University School of Medicine.
Follow us for late-breaking publications and submit your manuscripts at https://t.co/rxHoiE2OjS
Last Seen Users on Sotwe
Noc_IE
Seen from Russia
SHEMALE JAKARTA
Seen from Turkey
Emyy Strange
Seen from Germany
pashto sex
Seen from France
Dr nenen susuLolipop
Seen from Indonesia
Ari 🍑💨
Seen from United States
cenz racer
Seen from Indonesia
Geishakyd || BARCELONA 📍
Seen from Netherlands
.
Seen from Turkey
BitmapSoft 
Seen from United States
Most Popular Users
Elon Musk
@elonmusk
240.1M followers
Barack Obama
@barackobama
119.3M followers
Donald J. Trump
@realdonaldtrump
111.6M followers
Cristiano Ronaldo
@cristiano
108.8M followers
Narendra Modi
@narendramodi
106.9M followers
Rihanna
@rihanna
97.2M followers
NASA
@nasa
92.1M followers
Justin Bieber
@justinbieber
90.5M followers
KATY PERRY
@katyperry
86.7M followers
Taylor Swift
@taylorswift13
80.5M followers
Lady Gaga
@ladygaga
72.1M followers
Kim Kardashian
@kimkardashian
69.3M followers
YouTube
@youtube
68.6M followers
Virat Kohli
@imvkohli
68.4M followers
Bill Gates
@billgates
63.4M followers
The Ellen Show
@theellenshow
62.5M followers
CNN
@cnn
61.9M followers
Neymar Jr
@neymarjr
60.9M followers
X
@x
60.9M followers
CNN Breaking News
@cnnbrk
59.9M followers